Access cutting-edge multiple myeloma treatment through this phase 3 clinical trial at a research site in Augusta. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Augusta location
Preparing your pre-screening questions…
Access multiple myeloma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
Check if you qualify for this multiple myeloma clinical trial in Augusta, GA
No-Cost Study Care
Local to Augusta
Convenient for GA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Patients who receive a chemotherapy called melphalan are at high risk of having nausea and vomiting. A medication called olanzapine has been shown to decrease nausea and vomiting after chemotherapy. A previous research study found the 10 mg dose of olanzapine (combined with 3 standard medications used routinely to prevent nausea/vomiting) to be effective for patients who received melphalan chemotherapy, but several other studies have shown many patients have a side effect of sleepiness (e.g., sedation) with that dose of the medication. Our study will compare two lower doses of olanzapine (5 mg and 2.5 mg) in combination with the 3 standard medications used to prevent nausea/vomiting in the patients who receive melphalan chemotherapy to determine which dose is effective in preventing nausea and vomiting with the lowest amount of sleepiness side effect.
Sponsor: Augusta University
Yes, this clinical trial (NCT06588413) has an active research site in Augusta, GA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for multiple myeloma treatment options in Augusta, GA, this clinical trial (NCT06588413) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Augusta research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all multiple myeloma clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Augusta — not just this study.
Browse Multiple Myeloma Trials in Augusta →